Anti-Aggregating Antibodies, a New Approach Towards Treatment of Conformational Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|9|19|1737-1749

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.9, Iss.19, 2002-10, pp. : 1737-1749

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-PCSK9 Antibodies: A New Era in the Treatment of Dyslipidemia

By  

Current Pharmaceutical Design, Vol. 23, Iss. 10, 2017-05 ,pp. : 1484-1494

Bentham Science Publishers

Access to resources Recommend Favorite

Monoclonal Antibodies in the Treatment of Neuroimmunological Diseases

By  

Current Pharmaceutical Design, Vol. 18, Iss. 29, 2012-10 ,pp. : 4498-4507

Bentham Science Publishers

Access to resources Recommend Favorite

Humanized anti-EphB4 antibodies for the treatment of carcinomas and vasculogenesis-related diseases

By Xu Zenghui   Jin Huajun   Qian Qijun  

Expert Opinion on Therapeutic Patents, Vol. 19, Iss. 7, 2009-07 ,pp. : 1035-1037

Informa Healthcare

Access to resources Recommend Favorite

New Pharmaceutical Treatment of Gastric MALT Lymphoma: Anti-angiogenesis Treatment using VEGF Receptor Antibodies and Celecoxib

By  

Current Pharmaceutical Design, Vol. 20, Iss. 7, 2014-02 ,pp. : 1097-1103

Bentham Science Publishers

Access to resources Recommend Favorite

A Combined Approach with Rituximab Plus Anti-TRAIL-R Agonistic Antibodies for the Treatment of Haematological Malignancies

By  

Current Pharmaceutical Design, Vol. 14, Iss. 21, 2008-07 ,pp. : 2085-2099

Bentham Science Publishers

Access to resources Recommend Favorite